Negative Regulation of Histone Deacetylase 8 Activity by Cyclic AMP-Dependent Protein Kinase A

REFERENCES

• Ayer, D. E. 1999. Histone deacetylases: transcriptional repression with SINers and NuRDs. Trends Cell Biol. 9:193–198.
   PubMedGoogle Scholar
• Bannister, A. J., and Kouzarides T.. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384:641–643.
   PubMed Web of Science ®Google Scholar
• Bartl, S., Taplick J., Lagger G., Khier H., Kuchler K., and Seiser C.. 1997. Identification of mouse histone deacetylase 1 as a growth factor-inducible gene. Mol. Cell. Biol. 17:5033–5043.
   PubMed Web of Science ®Google Scholar
• Becker, P. B., and Horz W.. 2002. ATP-dependent nucleosome remodeling. Annu. Rev. Biochem. 71:247–273.
   PubMed Web of Science ®Google Scholar
• Berger, S. L. 2002. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev. 12:142–148.
   PubMed Web of Science ®Google Scholar
• Buggy, J. J., Sideris M. L., Mak P., Lorimer D. D., McIntosh B., and Clark J. M.. 2000. Cloning and characterization of a novel human histone deacetylase, HDAC8. Biochem. J. 350:199–205.
   PubMedGoogle Scholar
• Cai, R., Kwon P., Yan-Neale Y., Sambuccetti L., Fischer D., and Cohen D.. 2001. Mammalian histone deacetylase 1 protein is posttranslationally modified by phosphorylation. Biochem. Biophys. Res. Commun. 283:445–453.
   PubMedGoogle Scholar
• Canettieri, G., Morantte I., Guzman E., Asahara H., Herzig S., Anderson S. D., Yates III J. R., and Montminy M.. 2003. Attenuation of a phosphorylation-dependent activator by an HDAC-PP1 complex. Nat. Struct. Biol. 10:175–181.
   PubMedGoogle Scholar
• Chijiwa, T., Mishima A., Hagiwara M., Sano M., Hayashi K., Inoue T., Naito K., Toshioka T., and Hidaka H.. 1990. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265:5267–5272.
   PubMed Web of Science ®Google Scholar
• David, G., Neptune M. A., and DePinho R. A.. 2002. SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J. Biol. Chem. 277:23658–23663.
   PubMed Web of Science ®Google Scholar
• Durst, K. L., Lutterbach B., Kummalue T., Friedman A. D., and Hiebert S. W.. 2003. The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain. Mol. Cell. Biol. 23:607–619.
   PubMed Web of Science ®Google Scholar
• Finnin, M. S., Donigian J. R., Cohen A., Richon V. M., Rifkind R. A., Marks P. A., Breslow R., and Pavletich N. P.. 1999. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401:188–193.
   PubMed Web of Science ®Google Scholar
• Galasinski, S. C., Resing K. A., Goodrich J. A., and Ahn N. G.. 2002. Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions. J. Biol. Chem. 277:19618–19626.
   PubMed Web of Science ®Google Scholar
• Gangolli, E. A., Belyamani M., Muchinsky S., Narula A., Burton K. A., McKnight G. S., Uhler M. D., and Idzerda R. L.. 2000. Deficient gene expression in protein kinase inhibitor α null mutant mice. Mol. Cell. Biol. 20:3442–3448.
   PubMedGoogle Scholar
• Gao, L., Cueto M. A., Asselbergs F., and Atadja P.. 2002. Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family. J. Biol. Chem. 277:25748–25755.
   PubMed Web of Science ®Google Scholar
• Grozinger, C. M., and Schreiber S. L.. 2000. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. USA 97:7835–7840.
   PubMed Web of Science ®Google Scholar
• Hassig, C. A., Fleischer T. C., Billin A. N., Schreiber S. L., and Ayer D. E.. 1997. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89:341–347.
   PubMed Web of Science ®Google Scholar
• He, L. Z., Guidez F., Tribioli C., Peruzzi D., Ruthardt M., Zelent A., and Pandolfi P. P.. 1998. Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nat. Genet. 18:126–135.
   PubMed Web of Science ®Google Scholar
• He, T. C., Zhou S., da Costa L. T., Yu J., Kinzler K. W., and Vogelstein B.. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95:2509–2514.
   PubMed Web of Science ®Google Scholar
• Hu, E., Chen Z., Fredrickson T., Zhu Y., Kirkpatrick R., Zhang G. F., Johanson K., Sung C. M., Liu R., and Winkler J.. 2000. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor. J. Biol. Chem. 275:15254–15264.
   PubMed Web of Science ®Google Scholar
• Humphrey, G. W., Wang Y., Russanova V. R., Hirai T., Qin J., Nakatani Y., and Howard B. H.. 2001. Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1. J. Biol. Chem. 276:6817–6824.
   PubMed Web of Science ®Google Scholar
• Johnstone, R. W. 2002. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1:287–299.
   PubMed Web of Science ®Google Scholar
• Kelly, W. K., O'Connor O. A., and Marks P. A.. 2002. Histone deacetylase inhibitors: from target to clinical trials. Expert Opin. Investig. Drugs 11:1695–1713.
   PubMed Web of Science ®Google Scholar
• Kuo, M. H., and Allis C. D.. 1998. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20:615–626.
   PubMed Web of Science ®Google Scholar
• Laherty, C. D., Yang W. M., Sun J. M., Davie J. R., Seto E., and Eisenman R. N.. 1997. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89:349–356.
   PubMed Web of Science ®Google Scholar
• Lee, H., and Bai W.. 2002. Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation. Mol. Cell. Biol. 22:5835–5845.
   PubMed Web of Science ®Google Scholar
• Melnick, A., and Licht J. D.. 2002. Histone deacetylases as therapeutic targets in hematologic malignancies. Curr. Opin. Hematol. 9:322–332.
   PubMed Web of Science ®Google Scholar
• Michael, L. F., Asahara H., Shulman A. I., Kraus W. L., and Montminy M.. 2000. The phosphorylation status of a cyclic AMP-responsive activator is modulated via a chromatin-dependent mechanism. Mol. Cell. Biol. 20:1596–1603.
   PubMed Web of Science ®Google Scholar
• Neely, K. E., and Workman J. L.. 2002. The complexity of chromatin remodeling and its links to cancer. Biochim. Biophys. Acta 1603:19–29.
   PubMedGoogle Scholar
• Ng, H. H., and Bird A.. 2000. Histone deacetylases: silencers for hire. Trends Biochem. Sci. 25:121–126.
   PubMed Web of Science ®Google Scholar
• Ogryzko, V. V., Hirai T. H., Russanova V. R., Barbie D. A., and Howard B. H.. 1996. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol. Cell. Biol. 16:5210–5218.
   PubMed Web of Science ®Google Scholar
• Ogryzko, V. V., Schiltz R. L., Russanova V., Howard B. H., and Nakatani Y.. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953–959.
   PubMed Web of Science ®Google Scholar
• Pflum, M. K., Tong J. K., Lane W. S., and Schreiber S. L.. 2001. Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation. J. Biol. Chem. 276:47733–47741.
   PubMed Web of Science ®Google Scholar
• Robinson-White, A., and Stratakis C. A.. 2002. Protein kinase A signaling: “cross-talk” with other pathways in endocrine cells. Ann. N. Y. Acad. Sci. 968:256–270.
   PubMed Web of Science ®Google Scholar
• Schmitt, J. M., and Stork P. J.. 2001. Cyclic AMP-mediated inhibition of cell growth requires the small G protein Rap1. Mol. Cell. Biol. 21:3671–3683.
   PubMed Web of Science ®Google Scholar
• Sun, J. M., Chen H. Y., Moniwa M., Litchfield D. W., Seto E., and Davie J. R.. 2002. The transcriptional repressor Sp3 is associated with CK2-phosphorylated histone deacetylase 2. J. Biol. Chem. 277:35783–35786.
   PubMedGoogle Scholar
• Thiagalingam, S., Cheng K. H., Lee H. J., Mineva N., Thiagalingam A., and Ponte J. F.. 2003. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann. N. Y. Acad. Sci. 983:84–100.
   PubMed Web of Science ®Google Scholar
• Tong, J. K., Hassig C. A., Schnitzler G. R., Kingston R. E., and Schreiber S. L.. 1998. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 395:917–921.
   PubMed Web of Science ®Google Scholar
• Tsai, S. C., and Seto E.. 2002. Regulation of histone deacetylase 2 by protein kinase CK2. J. Biol. Chem. 277:31826–31833.
   PubMed Web of Science ®Google Scholar
• Van den Wyngaert, I., de Vries W., Kremer A., Neefs J., Verhasselt P., Luyten W. H., and Kass S. U.. 2000. Cloning and characterization of human histone deacetylase 8. FEBS Lett. 478:77–83.
   PubMed Web of Science ®Google Scholar
• Vigushin, D. M., and Coombes R. C.. 2002. Histone deacetylase inhibitors in cancer treatment. Anticancer Drugs 13:1–13.
   PubMed Web of Science ®Google Scholar
• Wade, P. A., Gegonne A., Jones P. L., Ballestar E., Aubry F., and Wolffe A. P.. 1999. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat. Genet. 23:62–66.
   PubMed Web of Science ®Google Scholar
• Wang, A. H., Kruhlak M. J., Wu J., Bertos N. R., Vezmar M., Posner B. I., Bazett-Jones D. P., and Yang X. J.. 2000. Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Mol. Cell. Biol. 20:6904–6912.
   PubMedGoogle Scholar
• Wharton, W., Savell J., Cress W. D., Seto E., and Pledger W. J.. 2000. Inhibition of mitogenesis in Balb/c-3T3 cells by trichostatin A. Multiple alterations in the induction and activation of cyclin-cyclin-dependent kinase complexes. J. Biol. Chem. 275:33981–33987.
   PubMedGoogle Scholar
• Yang, X. J., and Seto E.. 2003. Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression. Curr. Opin. Genet. Dev. 13:143–153.
   PubMed Web of Science ®Google Scholar
• You, A., Tong J. K., Grozinger C. M., and Schreiber S. L.. 2001. CoREST is an integral component of the CoREST-human histone deacetylase complex. Proc. Natl. Acad. Sci. USA 98:1454–1458.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Iratni R., Erdjument-Bromage H., Tempst P., and Reinberg D.. 1997. Histone deacetylases and SAP18, a novel polypeptide, are components of a human sin3 complex. Cell 89:357–364.
   PubMedGoogle Scholar
• Zhang, Y., LeRoy G., Seelig H. P., Lane W. S., and Reinberg D.. 1998. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 95:279–289.
   PubMed Web of Science ®Google Scholar